Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mohan N. Vishwanathan"'
Autor:
Sanjiv M. Narayan, Mohan N. Vishwanathan, Christopher A.B. Kowalewski, Tina Baykaner, Miguel Rodrigo, Junaid A.B. Zaman, Paul J. Wang
Publikováno v:
Revista Portuguesa de Cardiologia, Vol 36, Iss , Pp 9-17 (2017)
Pulmonary vein isolation (PVI) is central to ablation approaches for atrial fibrillation (AF), yet many patients still have arrhythmia recurrence after one or more procedures despite the latest technology for PVI. Ablation of rotational or focal sour
Externí odkaz:
https://doaj.org/article/2f54b4a2815748d38968ce6030f54488
Autor:
Junaid A.B. Zaman, Tina Baykaner, Paul J. Wang, Mohan N. Vishwanathan, Miguel Rodrigo, Sanjiv M. Narayan, Christopher A.B. Kowalewski
Publikováno v:
Revista Portuguesa de Cardiologia, Vol 36, Iss, Pp 9-17 (2017)
Revista Portuguesa de Cardiologia (English Edition), Vol 36, Iss, Pp 9-17 (2017)
Revista Portuguesa de Cardiologia (English Edition), Vol 36, Iss, Pp 9-17 (2017)
Pulmonary vein isolation (PVI) is central to ablation approaches for atrial fibrillation (AF), yet many patients still have arrhythmia recurrence after one or more procedures despite the latest technology for PVI. Ablation of rotational or focal sour
Autor:
John D. Day, David E. Krummen, John M. Miller, Moussa Mansour, Robert C. Kowal, John D. Hummel, Junaid A.B. Zaman, Amir A. Schricker, James P. Daubert, Tina Baykaner, Sanjiv M. Narayan, Paul Clopton, Paul J. Wang, Mohan N. Vishwanathan, Vijay Swarup, Shirley Park, Kevin R. Wheelan, Gery Tomassoni
Publikováno v:
JACC: Clinical Electrophysiology. 3:393-402
Objectives The purpose of this study was to determine the mechanistic overlap between paroxysmal and persistent forms of atrial fibrillation (AF), focusing on AF sources as a classification approach. Background The role of AF substrates is unclear in
Autor:
Junaid A.B. Zaman, Sanjiv M. Narayan, G. Meckler, Paul J. Wang, Tina Baykaner, Miguel Rodrigo, Mohan N. Vishwanathan, Christopher A.B. Kowalewski, F. Shenasa
Publikováno v:
Current Cardiovascular Risk Reports. 11
There is considerable interest in identifying potential drivers for human atrial fibrillation (AF), in order to improve therapy. Ablation via pulmonary vein isolation (PVI) is broadly used, yet is insufficient in many patients yet its outcomes are un